Omalizumab for the management of refractory aquagenic pruritus-Reference-Cited by-同舟云学术

Omalizumab for the management of refractory aquagenic pruritus

Published:2023-07-11 Issue:11 Volume:37 Page:
ISSN:0926-9959
Container-title:Journal of the European Academy of Dermatology and Venereology
language:en
Short-container-title:Acad Dermatol Venereol

Author:

Koumaki D.¹^ORCID,Gregoriou S.²^ORCID,Katoulis A.³^ORCID,Evangelou G.¹^ORCID

Affiliation:

1. Dermatology Department University Hospital of Heraklion Heraklion Greece

2. Department of Dermatology and Venereology, Andreas Sygros Hospital, Medical School of Athens National and Kapodistrian University of Athens Athens Greece

3. 2nd Department of Dermatology and Venereology, Medical School, “Attikon” General University Hospital National and Kapodistrian University of Athens Athens Greece

Publisher

Wiley

Subject

Infectious Diseases,Dermatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jdv.19306

Reference9 articles.

1. Clinical characteristics of aquagenic pruritus in patients with myeloproliferative neoplasms

2. Differences between aquagenic and non‐aquagenic pruritus in myeloproliferative neoplasms: An observational study of 500 patients

3. Aquagenic pruritus in polycythemia vera: Characteristics and influence on quality of life in 441 patients

4. Resolution of aquagenic pruritus with intermittent UVA/NBUVB combined therapy

5. Aquagenic pruritus successfully treated with omalizumab

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Histamine-H1-receptor-antagonists/histamine-H2-receptor-antagonists/methylprednisolone;Reactions Weekly;2024-01-13

2. Reply to ‘Omalizumab for the management of refractory aquagenic pruritus’;Journal of the European Academy of Dermatology and Venereology;2023-11-10